Showing 161 - 180 results of 103,922 for search '(( i fold decrease ) OR ( 5 ((((wt decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.42s Refine Results
  1. 161

    Discovery of a Colon-Targeted Azo Prodrug of Tofacitinib through the Establishment of Colon-Specific Delivery Systems Constructed by 5‑ASA–PABA–MAC and 5‑ASA–PABA–Diamine for the T... by Jiaxing Zhao (3965057)

    Published 2022
    “…Specifically, compound <b>20g</b> displayed a 3.67-fold decrease of plasma AUC<sub>(tofacitinib, 0–∞)</sub> and a 9.61-fold increase of colonic AUC<sub>(tofacitinib, 0–12h)</sub>, compared with tofacitinib at a molar equivalent oral dose. …”
  2. 162
  3. 163
  4. 164

    Transcriptomic and metabolomic analyses of liver of <i>Fmo5</i><sup><i>-/-</i></sup> and WT mice. by Ian R. Phillips (5074121)

    Published 2023
    “…<p>(A) Volcano plot representation of differentially expressed genes (log<sub>2</sub>-fold change) of <i>Fmo5</i><sup><i>-/-</i></sup> vs WT mice. …”
  5. 165

    Metabolites which were (A) reversibly decreased and (B) reversibly increased with smoking. by Charmion I. Cruickshank-Quinn (595143)

    Published 2014
    “…TG = triglyceride, CDP = cytidine-diphosphate, DG = diglyceride, PC = phosphatidylcholine, PS = phosphatidylserine, TG = triglyceride, PA = phosphatidic acid. Fold change ≥1.5; <i>p</i>-value≤0.05, x-axis = Log2 normalized abundance scale; Error bars represent 95% confidence; Significance values *≤0.05, **≤0.01, ***≤0.001.…”
  6. 166
  7. 167

    Presentation_1_Eosinophils Decrease Pulmonary Metastatic Mammary Tumor Growth.pptx by Rachel A. Cederberg (12827564)

    Published 2022
    “…We found that IL5Tg mice exhibit reduced pulmonary metastatic colonization and decreased metastatic tumor burden compared to wild-type (WT) mice or eosinophil-deficient mice. …”
  8. 168
  9. 169
  10. 170
  11. 171
  12. 172
  13. 173
  14. 174

    GluN2A(D731N) decreases channel open probability. by Kai Gao (120150)

    Published 2017
    “…The receptors were activated by EC<sub>50</sub> concentrations of glutamate with saturating concentration (100 μM) of glycine at holding potential of -40 mV. The di-heteromeric mutant (2A-D731N) and tri-heteromeric receptors with two-copies of the mutant subunit (D731N/D731N) showed a prolonged inhibition rate, reflecting a decreased channel open probability. …”
  15. 175
  16. 176
  17. 177
  18. 178
  19. 179
  20. 180